Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study-Reference-Cited by-同舟云学术

Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study

Published:2021-02-05 Issue:10 Volume:42 Page:4193-4202
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Cainazzo Maria Michela,Baraldi Carlo^ORCID,Ferrari Anna,Lo Castro Flavia,Pani Luca,Guerzoni Simona

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-021-05105-5.pdf

Reference39 articles.

1. Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1–211. https://doi.org/10.1177/0333102417738202

2. Diener HC, Holle D, Solbach K, Gaul C (2016) Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 12:575–583. https://doi.org/10.1038/nrneurol.2016.124

3. Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB (2012) Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 52:1456–1470. https://doi.org/10.1111/j.1526-4610.2012.02223.x

4. Lanteri-Minet (2014) Economic burden and costs of chronic migraine. Curr Pain Headache Rep 18:358. https://doi.org/10.1007/s11916-013-0385-0

5. Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L (2018) Complete detoxification is the most effective treatment of medication- overuse headache: a randomized controlled open-label trial. Cephalalgia 38:225–236. https://doi.org/10.1177/0333102417737779

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis;European Journal of Pharmacology;2024-08

2. Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache;Confinia Cephalalgica;2024-05-07

3. Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE;Neurology and Therapy;2023-10-04

4. Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies;Clinical Drug Investigation;2023-09

5. Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review;Medicine;2023-06-09